Volume 36 – Issue 4 – April, 2024
Publication: Journal of Invasive Cardiology Issue: Volume 36 – Issue 4 – April, 2024 Created: Fri, 04/05/2024 – 09:30 Volume 36 Issue 4
Publication: Journal of Invasive Cardiology Issue: Volume 36 – Issue 4 – April, 2024 Created: Fri, 04/05/2024 – 09:30 Volume 36 Issue 4
When George Richards couldn’t use his left arm, his friend immediately recognized the symptoms of a stroke. Within an hour, a clot was removed from…
BACKGROUND: The anatomy of myocardial fibers around the right cardiac veins (RCVs) and their roles in accessory pathways (APs) are rarely reported. METHODS: Six RCV-APs…
Myocardial electrical heterogeneity is critical for normal cardiac electromechanical function, but abnormal/excessive electrical heterogeneity is proarrhythmic. The spatial ventricular gradient (SVG), a vectorcardiographic measure of…
BACKGROUND: 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) has shown potential in protecting against heart disease, but its relationship with atrial fibrillation (AF) remains unknown. METHODS: C
BACKGROUND: In the PARTITA trial (Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator?), antitachycardia pacing (ATP) predicted
People living with HIV have a 1.5- to 2-fold increased risk of developing cardiovascular disease. Despite treatment with highly effective antiretroviral therapy, people living with…
Several signs of malignant early repolarizations (ERs) have been proposed in patients with ER syndrome (ERS). However, recent reports have challenged the efficacy of these…
### Learning objectives Cardiovascular disease (CVD) is the leading cause of mortality worldwide, resulting in ~18 million deaths annually.1 Atherosclerotic CVD (ASCVD) accounts for four out…
Tafamidis, a transthyretin stabilizer, is currently the standard of care for patients diagnosed with transthyretin amyloidosis (ATTR). Taking a comprehensive approach to the care of…
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.